BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 13, 2024

Total Value ($000): $4,611,779 (100.0% shares, 0.0% debt)

Holdings (4)

— CEREVEL THERAPEUTICS HLDNG I 60.4%

Value ($000) $2,784,823 Shares 65,679,781 Est. Cost $18.73 Unrealized —

SGRY SURGERY PARTNERS INC 34.6%

Value ($000) $1,597,804 Shares 49,946,972 Est. Cost $31.75 Unrealized -8.6%

AVAH AVEANNA HEALTHCARE HLDGS INC 4.7%

Value ($000) $218,690 Shares 81,600,880 Est. Cost $11.86 Unrealized -83.9%

ADV ADVANTAGE SOLUTIONS INC 0.2%

Value ($000) $10,462 Shares 2,890,000 Est. Cost $10.52 Unrealized -73.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CEREVEL THERAPEUTICS HLDNG I	65,679,781	$2,784,823	60.4%	$18.73	—	COM	15678U128
SGRY	SURGERY PARTNERS INC	49,946,972	$1,597,804	34.6%	$31.75	-8.6%	COM	86881A100
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$218,690	4.7%	$11.86	-83.9%	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$10,462	0.2%	$10.52	-73.0%	COM CL A	00791N102